Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies

A recent report estimated the breast cancer risks in carriers of the three Ashkenazi founder mutations to be higher than previously published estimates derived from population based studies. In an attempt to confirm this, the breast and ovarian cancer risks associated with the three Ashkenazi founde...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Antoniou, A, Pharoah, P, Narod, S, Risch, H, Eyfjord, J, Hopper, J, Olsson, H, Johannsson, O, Borg, A, Pasini, B, Radice, P, Manoukian, S, Eccles, D, Tang, N, Olah, E, Anton-Culver, H, Warner, E, Lubinski, J, Gronwald, J, Gorski, B, Tulinius, H, Thorlacius, S, Eerola, H, Nevanlinna, H, Syrjakoski, K, Kallioniemi, O, Thompson, D, Evans, C, Peto, J, Lalloo, F, Evans, D, Easton, D
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMJ Group 2005
Gaiak:
Letter to JMG
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC1736090/
https://ncbi.nlm.nih.gov/pubmed/15994883
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jmg.2004.024133
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak